Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 35 citing Kleefstra: Chromium treatment has no effect in patients with poorly controlled, insulin-treated.... (0.09 sec) 

Nutrition recommendations and interventions for diabetes--2006

- ksu.edu.sa [PDF] 
JP Bantle, RJ Wylie, AL Albright, CM …, 2006 - repository.ksu.edu.sa
M edical nutrition therapy (MNT) is important in preventing diabetes, managing
existing diabetes, and preventing, or at least slowing, the rate of development
of diabetes complications. It is, therefore, important at all levels of di- ...
Cited by 66 - Related articles - View as HTML - All 3 versions

Chromium picolinate supplementation attenuates body weight gain and increases insulin …

- diabetesjournals.org
J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were
evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide
gastrointestinal therapeutic system 5 mg/day) with placebo for 3 months. ...
Cited by 50 - Related articles - BL Direct - All 9 versions

Intensive insulin therapy in the intensive care unit

- diabetesjournals.org
C De Block… - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—During 48-h CGM, glycemia reached target (80–110 mg/dl) in only 22
± 18%, was >140 mg/dl in 39 ± 27%, and was <60 mg/dl in 5 ± 10% of the time.
Patients on subcutaneous versus intravenous insulin had more glycemia ...
Cited by 40 - Related articles - BL Direct - All 8 versions

Clinical studies on chromium picolinate supplementation in diabetes mellitus-a review


CL Broadhurst, P Domenico - Diabetes Technology & Therapeutics, 2006 - liebertonline.com
Chromium (Cr) picolinate (CrPic) is a widely used nutritional supplement for
optimal insulin function. A relationship among Cr status, diabetes, and
associated pathologies has been estab- lished. Virtually all trials using ...
Cited by 28 - Related articles - BL Direct - All 3 versions

Effect of Chromium Supplementation on Glucose Metabolism and Lipids

- diabetesjournals.org
EM Balk, A Tatsioni, AH Lichtenstein, J Lau, … - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—Forty-one studies met criteria, almost half of which were of poor
quality. Among participants with type 2 diabetes, chromium supplementation
improved glycosylated hemoglobin levels by −0.6% (95% CI −0.9 to ...
Cited by 22 - Related articles - BL Direct - All 13 versions

[PDF] Chromium picolinate and biotin combination improves glucose metabolism in treated, …


DMR Rev - Diabetes Metab Res Rev, 2008 - files.meetup.com
1Alpha Therapy Center, 4626 Weber Road, Suite 100, Corpus Christi, TX 78411;
361.852.0600 (voice), USA 2Global Medical Care, 5833 Spohn Drive, Suite # 301,
Corpus Christi, TX 78414; 361.880.4154 (voice), USA 3JERIKA Research ...
Cited by 13 - Related articles - View as HTML - BL Direct - All 5 versions

Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a …

- diabetesjournals.org
N Kleefstra, ST Houweling, SJL Bakker, S … - Diabetes Care, 2007 - Am Diabetes Assoc
OBJECTIVE—Chromium treatment has been reported to improve glycemic control in
patients with type 2 diabetes. However, concern exists about the possible toxic
effects of chromium picolinate. The aim of this study was to determine the ...
Cited by 12 - Related articles - BL Direct - All 8 versions

Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of …

- physiology.org
C Rink, S Roy, S Khanna, T Rink, D Bagchi, … - Physiological Genomics, 2006 - Am Physiological Soc
The effects of oral niacin-bound chromium (NBC) supplementation on the
subcutaneous fat tissue of type 2 Lepr db obese diabetic mice were examined
using high-density comprehensive mouse genome (45,101 probe sets) ...
Cited by 12 - Related articles - BL Direct - All 4 versions

[PDF] Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese …


N Sreejayan, F Dong, MR Kandadi, X Yang, J … - Obesity, 2008 - obesity-cme.abbmcertification.org
IntroductIon Insulin resistance, concomitant with diabetes, metabolic syn-
drome, obesity, and hypertension, is a major risk factor for the development and
progression of cardiovascular diseases, the leading causes of mortality and ...
Cited by 9 - Related articles - View as HTML - All 5 versions

Chromium picolinate and conjugated linoleic acid do not synergistically influence diet- …

- usda.gov [PDF] 
ML Diaz, BA Watkins, Y Li, RA Anderson, WW … - The Journal of nutritional biochemistry, 2008 - Elsevier
This study assessed the effects of combined chromium picolinate (CP) and
conjugated linoleic acid (CLA) supplementation on energy restriction and
exercise-induced changes in body composition, glucose metabolism, lipid ...
Cited by 7 - Related articles - All 11 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google